Filing Details

Accession Number:
0001578259-14-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-15 17:24:46
Reporting Period:
2014-07-11
Filing Date:
2014-07-15
Accepted Time:
2014-07-15 17:24:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827809 Qlt Inc QLTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360509 Florian Schonharting Ostergade 24A, 1
Dk-1100
Copenhagen K G7
No No Yes No
1451330 K/S Equity Public Nb Ostergade 24A, 1
Dk-1100
Copenhagen K G7
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Disposition 2014-07-11 1,000,000 $5.80 6,447,626 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owner.
  2. Florian Schonharting is a direct investor in a limited partner in the Fund and a director of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Mr. Schonharting disclaims beneficial ownership in the securities, except to the extent of his pecuniary interest therein.